[antineoplastic agent specific for the S phase of the cell cycle, used in combination with mechlorethamine, vincristine, and prednisone (MOPP protocol) in the treatment of Hodgkin's disease, and in treatment of other neoplasms. ( CSP )]
UMLS (NCI) C0033223 - Organic Chemical
- Pharmacologic Substance
Relation/PAR: [AN000] ANTINEOPLASTICS
Benzamides
hydrazine
Relation/CHD: Benzamide, N-(1-methylethyl)-4-[(2-methylhydrazino) methyl]-, monohydrochloride (9CI)